Savant Capital, LLC Tango Therapeutics, Inc. Transaction History
Savant Capital, LLC
- $15.3 Billion
- Q2 2025
A detailed history of Savant Capital, LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 11,872 shares of TNGX stock, worth $82,035. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,872Holding current value
$82,035% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNGX
# of Institutions
123Shares Held
97.8MCall Options Held
1.1KPut Options Held
2.7K-
Trv Gp Iv, LLC Boston, MA16.9MShares$116 Million88.92% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$74.2 Million3.54% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$73.5 Million1.14% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.53MShares$38.2 Million1.76% of portfolio
-
Nextech Invest Ag5.53MShares$38.2 Million3.19% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $609M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...